ArticlePloS one2009

Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.

Bérengère Vire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.